A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
Clinical trial NCT02030600 · COMPLETED
Trial details
- NCT number
- NCT02030600
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-06
- Primary completion
- 2015-12-04
- Enrollment
- 721
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.